FOXO4-DRI Benefits

Research Only Anti-Aging

Founder & Lead Researcher

Reviewed by Peptide Nerds Editorial · Updated April 2026

Not medical advice. This content is for educational purposes only. Consult a healthcare provider before starting any peptide protocol. Full disclaimer.

How FOXO4-DRI works

Disrupts the interaction between FOXO4 and p53 proteins in senescent cells, triggering apoptosis (cell death) specifically in damaged, non-functional cells.

Reported benefits

Based on preliminary research and anecdotal reports, FOXO4-DRI has been associated with the following benefits:

Selective senescent cell clearance
Potential tissue rejuvenation
Reduced age-related inflammation

Important context

Benefits reported in clinical trials represent average outcomes across study populations. Individual results vary based on genetics, dosage, duration, and lifestyle factors. This compound is not FDA-approved for human use. Benefits described are based on research data and should not be interpreted as therapeutic claims.

FOXO4-DRI overview Dosage protocol

Related peptides

Epitalon — Telomere elongation: Up to 33% telomere length increase observed in PHA-stimulated lymphocyte cultures from donors aged 25-88, though results varied substantially between individuals depending on baseline telomerase activity and cellular age. Normal cells treated with Epitalon bypassed the Hayflick limit, completing 44 passages vs. 34 in controls while maintaining youthful morphology (PMID: 15455129). This is an in vitro finding — whether similar extension occurs in living tissue remains unconfirmed. SS-31 — Mitochondrial function restoration

Free Peptide Weight Loss Guide

Semaglutide vs. tirzepatide vs. retatrutide. Dosing protocols, side effects, gray market sourcing, and what the clinical trials found.